Chad V. Pecot, MD (IMAGE)
Caption
“Targeting two cancer-causing genes at the same time is akin to slicing both Achilles heels of cancer, which has tremendous potential,” said Chad V. Pecot, MD, corresponding author of the article, professor of medicine at UNC School of Medicine. “Our inverted molecule establishes proof-of-concept for dual-silencing of KRAS and MYC in cancer and constitutes an innovative molecular strategy for co-targeting not just those two genes, but any two genes of interest, which has broad implications.”
Credit
UNC Lineberger Comprehensive Cancer Center
Usage Restrictions
None
License
Original content